2 completed, 1 active not recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Laboratory Biomarker: new trials by email Literature Review of Laboratory Biomarker trials Research Report on Laboratory Biomarker
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Detection of Lung Cancer Biospecimen Collection, Biospecimen collection, Pulmonary Function Test - Lung Cancer | Active not recruiting | Vanderbilt-Ingram Cancer Center | 45 | 2017-12-14 | 2026-05-05 | |
| Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer Atezolizumab, Carboplatin, Laboratory Biomarker - Triple Negative Breast Cancer, Stage IV Breast Cancer | Phase 2 | Completed | Vanderbilt-Ingram Cancer Center | 106 | 2017-08-29 | 2024-12-12 |
| Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer anti-PSMA monoclonal antibody MDX1201-A488, robot-assisted laparoscopic surgery, diffuse optical imaging - Adenocarcinoma of the Prostate, Stage IIB Prostate Cancer | Phase 1 | Completed | City of Hope Medical Center | 7 | 2015-10-05 | 2026-10-22 |
Breast Neoplasms (1) · Lung Neoplasms (1) · Prostatic Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Vanderbilt-Ingram Cancer Center (2) · City of Hope Medical Center (1)
United States (3)
Ali Zhumkhawala, MD (1) · Eric Grogan, MD (1)